Bristol-Myers Squibb Co vs United Parcel Service Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.61 (market cap $129.94B), while United Parcel Service Inc trades at $104.62 (market cap $88.85B). The key difference: Bristol-Myers Squibb Co is the larger of the two by market cap, and United Parcel Service Inc pays the higher dividend (6.28%). Which is the better fit depends on your goals.
| BMY | UPS | |
|---|---|---|
Market Cap | $129.94B | $88.85B |
Sector | Health | Industrials |
52-Week High | $65.89 | $120.00 |
52-Week Low | $42.60 | $82.58 |
Enterprise Value | $163.92B | $112.87B |
Dividend Yield | 3.96% | 6.28% |
Volume | — | 2,288,643 |
Trailing returns across standard periods
Latest headlines on both assets
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →